Objective: Levels of vitamin E have been reported to be lower in patients suffering major depression, but whether this is due to inadequate dietary intake or the pathophysiology of depression is not known, and was the subject of the present study. Setting: Wollongong, Australia. Methods: Plasma vitamin E (a-tocopherol) was measured in 49 adults with major depression, age (mean7s.d.): 47712 y. In a subset (n ¼ 19) usual dietary intake of vitamin E was determined by diet history. Results: Subjects had significantly lower plasma a-tocopherol (4.7170.13 mmol/mmol cholesterol) than has previously been reported for healthy Australians, and plasma a-tocopherol was inversely related to depression score (by Beck Depression Inventory) (r ¼ À0.367, Po0.009). Diet analysis indicated that 89% of subjects met or exceeded the recommended intake for vitamin E, and dietary intake was not related to plasma a-tocopherol level in this subset. Conclusion: These findings suggest that plasma levels of a-tocopherol are lower in depression, but this is not likely to be the result of inability to meet recommended dietary intake. Sponsorship: This study was supported in part by the Clover Corporation and the Australian Research Council.
Introduction
Oxidative stress, an imbalance between antioxidants and pro-oxidants in vivo, is suggested to be involved in major depression (Bilici et al, 2001 ). a-Tocopherol (vitamin E) is a major lipid soluble antioxidant in vivo and is an important defence against membrane damage from reactive radical species (Wang & Quinn, 1999) . Maes et al (2000) has reported lower serum levels of a-tocopherol in patients suffering from major depression compared to controls. In a recent study of elderly depressed subjects, plasma a-tocopherol levels were found to be lower only in males, compared to healthy controls (Tiemeier et al, 2002) , which the authors suggested might be due to a poor dietary intake. The aims of the present study were to examine the relationship between plasma a-tocopherol levels and depression score, and also to examine dietary vitamin E intake (measured as a-tocopherol equivalents) in a depressed subject group.
Methods
The present study examined plasma a-tocopherol levels, depression score and dietary vitamin E (as a-tocopherol equivalents) in depressed outpatient subjects recruited from the Illawarra region of NSW, Australia, through local health services and the University's Northfields Clinic. The study was granted approval by the University of Wollongong Human Research Ethics Committee, and subjects gave written informed consent. Inclusion criteria were age 18-70 y and satisfying the diagnostic criteria for major depression as the principle diagnosis (American Psychiatric Association, 1994) . Diagnoses were determined through a SCID interview by an experienced psychodiagnostician followed by consultation with a senior clinical psychologist. Exclusion criteria were a psychotic disorder, substance abuse, obsessive compulsive or bipolar disorder and serious medical illness. Plasma a-tocopherol and cholesterol levels were measured in 49 subjects (29 females (F), 20 males (M)), while dietary data are available for 19 subjects (12F, 7 M).
A fasted venous blood sample was taken into an EDTA tube and plasma separated by centrifugation (800 Â g) before storage at À801C. Plasma cholesterol was determined by enzymatic assay on a Cobas-Mira Plus (Roche Diagnostics, Australia). Plasma a-tocopherol was measured by high performance liquid chromatography with UV detection (Kock et al, 1997) . As there is a strong relationship between plasma cholesterol and a-tocopherol (McGavin et al, 2001) , plasma a-tocopherol results are expressed standardised to cholesterol (mmol a-tocopherol/mmol total cholesterol). Dietary intake was assessed by a dietitian by narrative diet history (Tapsell et al, 2000) and analysed using ESHA Food Processor (Version 8.0, ESHA Research, OR, USA). Depression scores were derived from administration of the Beck Depression Inventory (BDI).
Values for biochemical variables were given as mean7 s.e.m., unless otherwise stated. Statistical analyses were performed on Stata version 7 (Stata Corp., TX, USA) and SPSS version 10 (Chicago, IL, USA). Relationships were examined using Spearman's correlations and multiple regression. An unpaired t-test was used to compare plasma atocopherol levels between the study group and a previously reported healthy Australian group (Ward et al, 2002) .
Results
The levels of plasma a-tocopherol, total cholesterol and depression score for the study group are presented in Table 1 . A significant inverse relationship was noted between plasma a-tocopherol and depression score (r ¼ À0.367, P ¼ 0.009). There were no significant differences between males and females in depression score (M ¼ 26.4, F ¼ 24.1) or plasma a-tocopherol (M ¼ 4.5670.19, F ¼ 4.8270.18 mmol/mmol cholesterol), and no association between depression score and age, or plasma a-tocopherol and age. Mean plasma cholesterol levels were within the normal range (Table 1) , and there was no relationship seen between plasma cholesterol and depression score. There was no difference in plasma a-tocopherol between those patients taking (n ¼ 34) or not taking (n ¼ 15) antidepressant medication (4.6770.16 and 4.6070.28 mmol/mmol cholesterol, respectively). Multiple regression analysis revealed that the significance of the association between baseline a-tocopherol and depression score was reduced to a marginal level after controlling for sex and age (r ¼ À0.268, P ¼ 0.069). Plasma a-tocopherol levels in these depressed subjects were significantly lower than has been previously reported for healthy Australians (Ward et al, 2002 ) (4.7170.13 vs 5.6770.48 mmol/mmol cholesterol, respectively, Po0.05). Dietary analysis revealed that the Australian recommended daily intake (RDI) for vitamin E, (8 mg a-tocopherol equivalents) (NH & MRC, 1991) was met by 17 of 19 subjects, with the mean (7s.e.m.) intake being 25.172.8 mg. In the diet subgroup, mean plasma a-tocopherol level was 4.9170.19 mmol/mmol cholesterol. There was no correlation between plasma and dietary a-tocopherol intake.
Discussion
Mean plasma a-tocopherol in this group of depressed subjects was significantly lower than reported previously for a healthy Australian subject group (Ward et al, 2002) . In agreement with Maes et al (2000) , we found no significant effect of sex in the relationship between plasma a-tocopherol and depression; however, the significance of the association was diminished after controlling for age and sex. In contrast, Tiemeier et al (2002) found lower plasma a-tocopherol in depressed males only, and found the effect was no longer significant when other nutrition behaviour-related variables were taken into account. While the sample size in that study is larger, it also examined an elderly population (mean age 73 y). Increasing oxidative stress with postmaturational ageing is a widely held theory of biological ageing (Schoneich, 1999) , thus age differences between studies may be important. A longitudinal study in elderly Japanese also found no relationship between serum a-tocopherol and depression score, but found that in males only, a-tocopherol at baseline was a significant predictor of progression of depressive status at a 4 y follow-up (Shibata et al, 1999) . Conversely, levels of oxidative DNA damage were found to be positively associated to depression scores in female, but not male, Japanese workers (Irie et al, 2002) . These results indicate that it may be important to consider sex in further examination of the relationship between depression score and oxidative status. It has been suggested that successful treatment of depression with selective serotonin reuptake inhibitors might reduce levels of oxidative stress (Bilici et al, 2001) , but further work is needed to establish causality in the relationship between depression and oxidative stress.
Measurement of a single antioxidant is limited in its ability to comprehensively measure oxidative stress; however, there is evidence to support the use of plasma a-tocopherol as a Low plasma vitamin E levels AJ Owen et al biomarker.
In an examination of the oxidative stress imposed by cigarette smoking, plasma a-tocopherol was found to be negatively correlated to the lipid oxidation product malondialdehyde (Liu et al, 1998) , which has previously been found to be higher in depressed patients than controls (Bilici et al, 2001) . The present study is also limited by the lack of a study-specific control (nondepressed) group; however, we have no reason to suspect that residents of the Illawarra region, a coastal community within 100 km of Australia's largest city, differ significantly in their dietary vitamin E intake from the average Australian intake. Depression has previously been suggested to be associated with low plasma cholesterol (Morgan et al, 1993) , although this has not been seen consistently (Freedman et al, 1995) . The mean cholesterol level of the present sample was well within the normal range and we found no association between cholesterol and depression score in these subjects. Further examination of the relationship between age, plasma cholesterol, a-tocopherol and depression is warranted and will require a larger sample size than was available for the current study in order to examine the interactions between these variables. The findings of the present study suggest that a-tocopherol (vitamin E) levels are lower in depression, which is in agreement with the findings of others (Maes et al, 2000) . The adequacy of a-tocopherol intake, coupled with the lack of association between plasma levels and dietary intake of atocopherol, suggests that lower plasma levels of a-tocopherol are less likely to be due to poor diet and may be due to some other factor associated with major depression. Further research is needed to determine whether low plasma vitamin E might be reflective of increased oxidative stress in major depression, which will require disease-specific validation of oxidative stress biomarkers.
